1. Home
  2. KW vs IOVA Comparison

KW vs IOVA Comparison

Compare KW & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • IOVA
  • Stock Information
  • Founded
  • KW 1977
  • IOVA 2007
  • Country
  • KW United States
  • IOVA United States
  • Employees
  • KW N/A
  • IOVA N/A
  • Industry
  • KW Real Estate
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KW Finance
  • IOVA Health Care
  • Exchange
  • KW Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • KW 940.4M
  • IOVA 771.4M
  • IPO Year
  • KW 1992
  • IOVA N/A
  • Fundamental
  • Price
  • KW $7.46
  • IOVA $2.00
  • Analyst Decision
  • KW Hold
  • IOVA Buy
  • Analyst Count
  • KW 1
  • IOVA 10
  • Target Price
  • KW $13.00
  • IOVA $12.22
  • AVG Volume (30 Days)
  • KW 1.2M
  • IOVA 11.2M
  • Earning Date
  • KW 08-06-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • KW 6.43%
  • IOVA N/A
  • EPS Growth
  • KW N/A
  • IOVA N/A
  • EPS
  • KW N/A
  • IOVA N/A
  • Revenue
  • KW $514,600,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • KW $31.15
  • IOVA $86.62
  • Revenue Next Year
  • KW $2.98
  • IOVA $69.95
  • P/E Ratio
  • KW N/A
  • IOVA N/A
  • Revenue Growth
  • KW N/A
  • IOVA 11070.12
  • 52 Week Low
  • KW $5.98
  • IOVA $1.64
  • 52 Week High
  • KW $11.88
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • KW 69.43
  • IOVA 47.70
  • Support Level
  • KW $7.16
  • IOVA $1.68
  • Resistance Level
  • KW $7.63
  • IOVA $1.82
  • Average True Range (ATR)
  • KW 0.23
  • IOVA 0.11
  • MACD
  • KW 0.07
  • IOVA 0.02
  • Stochastic Oscillator
  • KW 84.23
  • IOVA 51.14

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: